Vandana Singh
·
August 11, 2025
Benzinga
Vinay Prasad returns as FDA's CBER director after brief exit, raising questions on rare disease drug approvals and mRNA vaccine oversight.
read more
August 20, 2025
July 24, 2025
Barchart
July 29, 2025
Bloomberg